Literature DB >> 19298387

Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.

Gabriella Fanali1, Giorgio Pariani, Paolo Ascenzi, Mauro Fasano.   

Abstract

Human serum albumin (HSA) is known for its exceptional ligand-binding capacity; indeed, its modular domain organization provides a variety of ligand-binding sites. Its flexible modular structure involves more than the immediate vicinity of the binding site(s), affecting the ligand-binding properties of the whole protein. Here, biochemical characterization by (1)H-NMR relaxometry and optical spectroscopy of a truncated form of HSA (tHSA) encompassing domains I and II (Asp1-Glu382) is reported. Removal of the C-terminal domain III results in a number of contacts that involve domain I (containing the heme site) and domain II (containing the warfarin site) being lost; however, the allosteric linkage between heme and warfarin sites is maintained. tHSA shows a nuclear magnetic relaxation dispersion profile similar to that of HSA, and displays increased affinity for ibuprofen, warfarin, and heme, suggesting that the fold is preserved. Moreover, the allosteric properties that make HSA a peculiar monomeric protein and account for the regulation of ligand-binding modes by heterotropic interactions are maintained after removal of domain III. Therefore, tHSA is a valuable model with which to investigate allosteric properties of HSA, allowing independent analysis of the linkages between different drug-binding sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298387     DOI: 10.1111/j.1742-4658.2009.06952.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  9 in total

1.  Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.

Authors:  Paolo Ascenzi; Alessandro Bolli; Alessandra di Masi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2010-09-25       Impact factor: 3.358

2.  Polycatechol Nanoparticle MRI Contrast Agents.

Authors:  Yiwen Li; Yuran Huang; Zhao Wang; Fabio Carniato; Yijun Xie; Joseph P Patterson; Matthew P Thompson; Christopher M Andolina; Treffly B Ditri; Jill E Millstone; Joshua S Figueroa; Jeffrey D Rinehart; Miriam Scadeng; Mauro Botta; Nathan C Gianneschi
Journal:  Small       Date:  2015-12-17       Impact factor: 13.281

3.  Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.

Authors:  Yu Cao; Francesco P Nicoletti; Giampiero De Sanctis; Alessio Bocedi; Chiara Ciaccio; Francesca Gullotta; Gabriella Fanali; Grazia R Tundo; Alessandra di Masi; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

4.  Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.

Authors:  Paolo Ascenzi; Alessandra di Masi; Massimo Coletta; Chiara Ciaccio; Gabriella Fanali; Francesco P Nicoletti; Giulietta Smulevich; Mauro Fasano
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

5.  The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.

Authors:  Carlo Meneghini; Loris Leboffe; Monica Bionducci; Gabriella Fanali; Massimiliano Meli; Giorgio Colombo; Mauro Fasano; Paolo Ascenzi; Settimio Mobilio
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 6.  Heme-based catalytic properties of human serum albumin.

Authors:  P Ascenzi; A di Masi; G Fanali; M Fasano
Journal:  Cell Death Discov       Date:  2015-09-07

7.  Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin.

Authors:  Alessio Bocedi; Giampiero De Sanctis; Chiara Ciaccio; Grazia R Tundo; Alessandra Di Masi; Gabriella Fanali; Francesco P Nicoletti; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

8.  An albumin-derived peptide scaffold capable of binding and catalysis.

Authors:  Immacolata Luisi; Silvia Pavan; Giampaolo Fontanive; Alessandro Tossi; Fabio Benedetti; Adriano Savoini; Elisa Maurizio; Riccardo Sgarra; Daniele Sblattero; Federico Berti
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Binding of Sulpiride to Seric Albumins.

Authors:  Viviane Muniz da Silva Fragoso; Carla Patrícia de Morais Coura; Luanda Yanaan Hoppe; Marília Amável Gomes Soares; Dilson Silva; Celia Martins Cortez
Journal:  Int J Mol Sci       Date:  2016-01-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.